Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT AMYLYX PHARMACEUTICALS, INC.

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX)
Listen to this Section


$18.53
+1.0800 ( +6.19% ) 1.1M

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.

Market Data


Open $18.53
Previous Close $17.45
Volume 1.1M
Market Cap $1.94B
Day Range $17.13 - $18.86
52 Week Range $7.48 - $19.15
Shares Outstanding 111.19M
Change % +6.19%
Net Change ▲ 1.0800
Insider Ownership 0.00%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2022
CountryUnited States
UnderwriterGoldman Sachs, Leerink Partners, Evercore ISI, H.C. Wainwright, more

Insider Ownership Transactions

Total Amount Purchased: -3,245,337.00

Date Type Amount Purchased Purchaser
2024-09-16 Buy 40000.00 FRATES JAMES M
2024-09-09 Buy 50000.00 Firestone Karen
2024-09-05 Buy 100000.00 MILNE GEORGE M JR
2024-06-07 Sale -25000.00 Quimi Daphne
2024-06-07 Sale -25000.00 MILNE GEORGE M JR
2024-06-07 Sale -25000.00 FONTEYNE PAUL R.
2024-06-07 Sale -25000.00 Firestone Karen
2024-06-07 Sale -5753.00 Zeiher Bernhardt G
2024-05-16 Sale -10455.00 Mazzariello Gina
2024-05-16 Buy 2750.00 Quimi Daphne

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 57 Aug 07, 2025
8-k 8K-related 12 Aug 07, 2025

Latest News